U.S. Other Utilities Stock News

Tejon Ranch (TRC) has just wrapped up FY 2025 with fourth quarter revenue of US$21.1 million and basic EPS of US$0.06, while the full year on a trailing 12 month basis came in at US$49.6 million of revenue and essentially breakeven EPS around US$0.00. Over recent quarters, the company has seen revenue move from US$8.3 million and basic EPS of a US$0.06 loss in Q2 2025 to US$11.0 million and a US$0.06 loss in Q3 2024, before reaching Q4 2025’s US$21.1 million and US$0.06 EPS. This sets up a...

In early March 2026, FTI Consulting’s Technology segment reported growing adoption of its IQ.AI platform among major corporate legal departments and law firms and introduced IQ.AI Studio, a proprietary library of generative AI tasks, models and workflows for complex legal, regulatory and investigation matters across multiple regions. The company highlighted that IQ.AI has already been used on hundreds of matters to compress timelines, reduce manual review workloads and extract structured...

Baxter International (BAX) is back in focus after chief financial officer Joel Grade stepped down. Interim CFO Anita Zielinski is stepping in as legal and governance questions around the Novum LVP infusion pump draw fresh investor attention. See our latest analysis for Baxter International. The share price has retreated sharply to US$16.66, with a 30 day share price return of a 19.67% decline and a 1 year total shareholder return of a 49.50% loss, reflecting fading momentum as investors...

Recently, Photronics reported a strong quarter with revenue increasing 6.1% year on year, surpassing analyst estimates for both sales and earnings per share. Management also emphasized that facility expansion and efforts to broaden the company’s geographic revenue mix are progressing, reflecting how it is adapting its photomask business to a more regionally segmented semiconductor industry. With this earnings beat and reaffirmed progress on facility expansion, we’ll now examine how the...

GameStop’s acquisition speculation and transformation plans draw investor focus GameStop (GME) is back in the spotlight as speculation over a possible acquisition of a publicly traded consumer company intersects with CEO Ryan Cohen’s push toward e-commerce, collectibles, and accelerated store closures. See our latest analysis for GameStop. Speculation around a potential acquisition and Cohen’s push to reshape the business have arrived during a choppy period for the stock. The share price has...

Accenture (ACN) has reported Q2 2026 results with revenue of US$18.0b and basic EPS of US$2.96, setting the tone for how its consulting and technology services engine is currently translating into top and bottom line performance. The company has seen quarterly revenue move from US$16.7b in Q2 2025 to US$18.0b in Q2 2026, while basic EPS over the same quarters has shifted from US$2.85 to US$2.96, giving investors a clear read on how sales and earnings are tracking together. With a trailing net...

Movado Group (MOV) has wrapped up FY 2026 with fourth quarter revenue of US$191.6 million and basic EPS of US$0.55, supported by trailing twelve month revenue of US$671.3 million and EPS of US$1.17, alongside a 44.6% earnings increase over the past year. Over recent quarters, the company has seen revenue move from US$174.7 million and EPS of US$0.30 in Q4 FY 2025 to US$191.6 million and EPS of US$0.55 in Q4 FY 2026. At the same time, trailing net profit margin has shifted from 2.8% to 4%,...

Why IDT Is On Investors’ Radar Today IDT (IDT) has drawn fresh attention after recent trading saw mixed short term share performance, with a 1 day gain alongside weaker moves over the week, month and past 3 months. That divergence, combined with its current US$47.79 share price and roughly US$1.18b market cap, is prompting closer scrutiny of how the company’s communications and payments segments are contributing to revenue and earnings. See our latest analysis for IDT. Set against a 1 day...

A class action lawsuit has been filed against Soleno Therapeutics (NasdaqCM:SLNO) alleging failures to disclose significant safety concerns in clinical trials for its drug DCCR. The complaint targets the company and certain executives, claiming that undisclosed issues could affect DCCR's commercial prospects and Soleno's reputation. The case focuses on the period around the development and launch preparations of DCCR, Soleno's sole commercial product. Soleno Therapeutics is a biotech...

Aveanna Healthcare Holdings (AVAH) delivers full year 2025 results Aveanna Healthcare Holdings (AVAH) has wrapped up FY 2025 with fourth quarter revenue of US$662.5 million, basic EPS of US$0.85 and net income excluding extraordinary items of US$178.8 million. This frames a year where trailing twelve month revenue reached about US$2.4 billion and basic EPS was US$1.11. Over recent periods the company has seen revenue move from US$519.9 million in Q4 FY 2024 to US$662.5 million in Q4 FY 2025,...

Oracle (ORCL) has been back in focus after reporting financial results that topped expectations, paired with strong guidance, large AI related contract backlogs, and fresh product launches across healthcare and developer tools. See our latest analysis for Oracle. Despite upbeat earnings and AI headlines, Oracle’s 1 day share price return of 1.71% and 90 day share price return of 18.99% show that recent momentum still lags its earlier surge. At the same time, the 5 year total shareholder...

Yiren Digital’s FY 2025 Results Put Margins Under the Microscope Yiren Digital (NYSE:YRD) has just closed out FY 2025 with fourth quarter revenue of C¥957.6 million and a loss per share of C¥10.12, as net income excluding extra items came in at a loss of C¥882.2 million against a C¥2.03 share price. The company has seen quarterly revenue range from C¥1,652.1 million in Q2 2025 to C¥1,452.2 million in Q4 2024. Basic EPS moved from a profit of C¥3.84 in Q4 2024 to a loss in the latest quarter,...

Why the Ford partnership matters for Bread Financial Bread Financial Holdings (BFH) is back in focus after Ford Motor Company selected it for a long term co-branded credit card and installment loan program tied directly into Ford’s customer platforms. The market reaction has been constructive, with the stock recently up 3.1% alongside broader gains in financial names, as investors consider what this new Ford relationship could mean for Bread Financial’s card services and lending...

If you are trying to work out whether Nuvation Bio is attractively priced or not, the recent share performance gives you some useful starting clues. At a last close of US$4.26, the stock has seen a 2.5% decline over the past week and a 27.6% decline over the past month, but is up 117.3% over 1 year and 156.6% over 3 years. Over 5 years, the return sits at a 59.4% decline. This mix of shorter term weakness and longer term strength has put valuation in sharper focus for many investors. With...

In March 2026, CF Industries Holdings filed a definitive proxy statement urging shareholders to vote against a proposal to require investor approval for any Named Executive Officer severance package exceeding 2.99 times base salary plus target bonus, while also facing antitrust litigation, progressing a blue ammonia pivot, executing large buybacks, and securing a US$169.50 million legal settlement. This combination of governance tension over executive pay, legal scrutiny, clean-energy...

L3Harris Technologies (NYSE:LHX) has agreed to partner with Intuitive Machines’ Lanteris Space Systems on spacecraft platforms for the Space Development Agency’s Tranche 3 Tracking Layer. The program supports real time tracking of missile threats for U.S. defense customers. This partnership expands L3Harris’s role in U.S. missile defense infrastructure, an area not covered in recent company discussions focused on valuation, leadership, and segment realignments. L3Harris operates at the...

Hyperfine (HYPR) closed out FY 2025 with Q4 revenue of US$5.3 million and a net loss of US$5.9 million, equal to a basic EPS loss of US$0.06. On a trailing twelve month basis it generated US$13.6 million of revenue and a total net loss of US$35.6 million, or a basic EPS loss of US$0.43. Over the past four reported quarters, revenue has moved from US$2.1 million in Q1 2025 to US$5.3 million in Q4 2025, while quarterly basic EPS losses ranged between US$0.06 and US$0.14 per share. This keeps...

Canadian Solar Inc. recently reported fourth-quarter 2025 results showing sales of US$1,217.21 million and a net loss of US$86.34 million, with the full year turning from profit to a net loss of US$104.13 million on lower sales of US$5,595.11 million. Alongside these weaker earnings, the company highlighted growing momentum in its energy storage business, including a sizeable U.S. battery project win and increased storage shipments, underscoring a shift in where future growth may come...

Palantir Technologies (NasdaqGS:PLTR) is partnering with Moder to launch an AI powered mortgage operations platform for Freedom Mortgage. The move brings Palantir's Ontology and agentic AI framework into core mortgage workflows, expanding its footprint beyond government and defense clients. Early implementation results point to operational gains and a new commercial use case in a conservative, data heavy financial sector. For investors tracking Palantir, the Moder and Freedom Mortgage...

LexinFintech Holdings (NasdaqGS:LX) FY 2025 earnings snapshot LexinFintech Holdings (NasdaqGS:LX) has wrapped up FY 2025 with fourth quarter revenue of C¥3,043.1 million and basic EPS of C¥1.27, capping a year where trailing twelve month revenue came in at C¥13.2 billion and EPS reached C¥9.90. Over the past few quarters the company has seen revenue move from C¥3,587.4 million in Q2 2025 to C¥3,417.5 million in Q3 2025 and then C¥3,043.1 million in Q4 2025, while quarterly EPS shifted from...

Wondering if Sezzle at around US$66.24 is priced for its future or offering value today? This breakdown is built to help you frame that question clearly. The stock has logged returns of 1.5% over the last 7 days, 4.5% over 30 days, and 71.3% over the past year, which naturally raises questions about how much of the story is already in the price. Recent coverage has focused on Sezzle's position in the diversified financials space and ongoing investor interest in buy now, pay later providers,...

Theravance Biopharma (TBPH) has wrapped up FY 2025 with Q4 revenue of US$45.9 million and Basic EPS of US$1.20, alongside trailing 12 month revenue of US$107.5 million and Basic EPS of US$2.10. Over the past year, revenue has moved from US$64.4 million to US$107.5 million on a trailing 12 month basis, while Basic EPS shifted from a trailing 12 month loss of US$1.15 to a profit of US$2.10. This frames a clear turn in the earnings profile as margins improved. See our full analysis for...

Dana (DAN) has caught investor attention after a solid past 3 months, with the stock up about 34% and a year total return above 120%. This has prompted fresh questions about valuation and durability. See our latest analysis for Dana. The recent 34.3% 90 day share price return, alongside a 124.9% total shareholder return over the past year, points to strong momentum as the market reconsiders Dana’s prospects and risk profile at a share price of $31.88. If Dana’s move has you thinking about...

One Stop Systems (OSS) has put up a mixed FY 2025 scorecard so far, with Q3 revenue of about US$18.8 million and basic EPS of roughly US$0.01, alongside trailing 12 month revenue of about US$60.3 million and a loss of roughly US$6.9 million on a basic EPS basis of about US$0.32. The company has seen quarterly revenue move from about US$13.2 million in Q2 2024 to US$15.1 million in Q4 2024, then to US$12.3 million in Q1 2025, US$14.1 million in Q2 2025 and US$18.8 million in Q3 2025. Basic EPS...